scholarly journals PRS25 CO-MORBID CHRONIC NON-CANCER PAIN IS ASSOCIATED WITH HIGHER HEALTHCARE UTILIZATION AND COSTS IN INDIVIDUALS DIAGNOSED WITH OBSTRUCTIVE SLEEP APNEA

2019 ◽  
Vol 22 ◽  
pp. S353-S354
Author(s):  
A.B. Gandhi ◽  
J. Slejko ◽  
E. Villalonga Olives ◽  
A. Olopoenia ◽  
E. Onukwugha
Author(s):  
Ritwick Agrawal ◽  
Andrew M. Spiegelman ◽  
Venkata D. Bandi ◽  
Max Hirshkowitz ◽  
Amir Sharafkhaneh

2008 ◽  
Vol 11 (7) ◽  
pp. 1043-1045 ◽  
Author(s):  
Suresh K. Reddy ◽  
Nhunhu Nguyen ◽  
Badi El Osta ◽  
Eduardo Bruera

2021 ◽  
Author(s):  
Ritwick Agrawal ◽  
Andrew M. Spiegelman ◽  
Venkata D. Bandi ◽  
Max Hirshkowitz ◽  
Amir Sharafkhaneh

2020 ◽  
Vol 10 (6) ◽  
pp. 377-386
Author(s):  
Aakash Bipin Gandhi ◽  
Julia F Slejko ◽  
Ester Villalonga-Olives ◽  
Emerson M Wickwire ◽  
Abisola Olopoenia ◽  
...  

Aim: To evaluate the impact of chronic non-cancer pain (CNCP) on healthcare use and costs among individuals diagnosed with obstructive sleep apnea (OSA). Materials & methods: Using the IQVIA PharMetrics® Plus database, we identified individuals (18–64 years old) during 2007–2014, divided into two groups: OSA + CNCP versus OSA-only. Generalized linear models were used to analyze binary and count outcomes. Results: Relative to OSA-only controls, OSA + CNCP cases had increased odds for inpatient and emergency department visits and higher rates for physician office visits, non-physician outpatient visits, and prescription drug fills. Relative to controls, direct healthcare costs for cases were higher, primarily driven by inpatient and non-physician outpatient visit costs. Conclusion: Relative to OSA-only controls, OSA + CNCP cases displayed increased healthcare use and costs across all points of service.


SLEEP ◽  
2006 ◽  
Vol 29 (10) ◽  
pp. 1307-1311 ◽  
Author(s):  
Katsuhisa Banno ◽  
Jure Manfreda ◽  
Randy Walld ◽  
Kenneth Delaive ◽  
Meir H. Kryger

2017 ◽  
Vol 38 ◽  
pp. 73-77 ◽  
Author(s):  
Robert J. Walter ◽  
Scott I. Hagedorn ◽  
Christopher J. Lettieri

2014 ◽  
Vol 9 (2) ◽  
pp. 92 ◽  
Author(s):  
Paola Faverio ◽  
Angela Hospenthal ◽  
MarcosI Restrepo ◽  
MeganE Amuan ◽  
Mary JoV Pugh ◽  
...  

2019 ◽  
Vol 4 (5) ◽  
pp. 878-892
Author(s):  
Joseph A. Napoli ◽  
Linda D. Vallino

Purpose The 2 most commonly used operations to treat velopharyngeal inadequacy (VPI) are superiorly based pharyngeal flap and sphincter pharyngoplasty, both of which may result in hyponasal speech and airway obstruction. The purpose of this article is to (a) describe the bilateral buccal flap revision palatoplasty (BBFRP) as an alternative technique to manage VPI while minimizing these risks and (b) conduct a systematic review of the evidence of BBFRP on speech and other clinical outcomes. A report comparing the speech of a child with hypernasality before and after BBFRP is presented. Method A review of databases was conducted for studies of buccal flaps to treat VPI. Using the principles of a systematic review, the articles were read, and data were abstracted for study characteristics that were developed a priori. With respect to the case report, speech and instrumental data from a child with repaired cleft lip and palate and hypernasal speech were collected and analyzed before and after surgery. Results Eight articles were included in the analysis. The results were positive, and the evidence is in favor of BBFRP in improving velopharyngeal function, while minimizing the risk of hyponasal speech and obstructive sleep apnea. Before surgery, the child's speech was characterized by moderate hypernasality, and after surgery, it was judged to be within normal limits. Conclusion Based on clinical experience and results from the systematic review, there is sufficient evidence that the buccal flap is effective in improving resonance and minimizing obstructive sleep apnea. We recommend BBFRP as another approach in selected patients to manage VPI. Supplemental Material https://doi.org/10.23641/asha.9919352


Sign in / Sign up

Export Citation Format

Share Document